RQS
CNCE

Ramsey Quantitative Systems’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Ramsey Quantitative Systems’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-73,383
Closed -$824K – 169
2016
Q2 		$824K Buy
73,383
+38,102
+108% +$485K 0.9% 18
2016
Q1 		$482K Buy
35,281
+11,517
+48% +$166K 0.49% 136
2015
Q4 		$451K Buy
+23,764
New +$516K 0.48% 151

Other funds holding CNCE

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ramsey Quantitative Systems's CNCE Position: Q3 2016 in Review

Ramsey Quantitative Systems sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q3 2016, closing a stake of 73,383 shares — an estimated $824K sold.

Ramsey Quantitative Systems first reported a position in CNCE in Q4 2015 and held it in 3 quarters. The position peaked at $824K in Q2 2016. 94 funds tracked by Wall St. Rank hold CNCE as of Q3 2016.

  • Ramsey Quantitative Systems reported no remaining Concert Pharmaceuticals, Inc. position as of Q3 2016 after selling out during the quarter.
  • Ramsey Quantitative Systems sold 73,383 Concert Pharmaceuticals, Inc. shares in Q3 2016, an estimated $824K.
  • Ramsey Quantitative Systems first reported a position in Concert Pharmaceuticals, Inc. in Q4 2015 and held it in 3 quarters.
  • Ramsey Quantitative Systems's Concert Pharmaceuticals, Inc. position peaked at $824K in Q2 2016.
  • 94 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q3 2016.

Based on Ramsey Quantitative Systems's 13F filing for Q3 2016, filed 14 Nov 2016.